Gastrointestinal Stromal Tumors

June 1, 2018

SU11248 Effective in Gastrointestinal Stromal Tumors (GIST)

Charles H. Weaver, MD
May 25, 2018

Protein Mutations May Predict Outcomes for GIST Patients Treated with Gleevec®

Charles H. Weaver, MD
October 7, 2014

Gastrointestinal Carcinoid Tumor: Lanreotide Is a Convenient, Effective Drug

Charles H. Weaver, MD
March 9, 2010

Should Oncologists Give Cancer Patients A Survival Timeline?

Charles H. Weaver, MD
March 8, 2009

Regorafenib May Expand GIST Treatment Options

Charles H. Weaver, MD
March 8, 2009

Sutent® Approved for GIST

Charles H. Weaver, MD
March 8, 2009

Two-gene Test Correctly Distinguishes GIST from Leiomyosarcoma

Charles H. Weaver, MD
March 8, 2009

Postoperative Enteral Nutrition Reduces Complications in Gastrointestinal Cancer

Charles H. Weaver, MD
June 21, 2007

Sutent® Improves Outcomes for Patients with GIST

Charles H. Weaver, MD